Show simple item record

dc.contributor.authorRodriguez-Morales, A.J.
dc.contributor.authorFranco, O.H.
dc.date.accessioned2025-10-31T18:32:11Z
dc.date.available2025-10-31T18:32:11Z
dc.date.issued2022
dc.identifier.urihttps://hdl.handle.net/20.500.12805/4515
dc.description.abstractFollowing their introduction towards the end of 2020, COVID-19 vaccines have been evaluated in terms of prevention of complications, hospitalisation rates, and mortality levels among those who are vaccinated compared with those who are not. Assessing the efficacy of vaccines is crucial for their use, but studies that assess real-world effectiveness of vaccines are also highly relevant, especially those comparing the efficacy of available vaccines in a specific country and those assessing efficacy in specific population groups that differ on certain factors (eg, age and gender)...en_US
dc.formatapplication/pdf
dc.language.isoeng
dc.publisherElsevier
dc.relation.ispartofurn:issn:2666-7568
dc.rightshttps://purl.org/coar/access_right/c_abf2
dc.rights.urihttps://creativecommons.org/licenses/by-nc-sa/4.0/
dc.subjectCOVID-19, Its Impact, and Vaccinationen_US
dc.subjectVaccine Efficacy and Immune Response in COVID-19en_US
dc.titleAssessing the effectiveness of COVID-19 vaccines in older people in Latin Americaen_US
dc.typehttps://purl.org/coar/resource_type/D97F-VB57
dc.identifier.doihttps://doi.org/10.1016/S2666-7568(22)00073-3
dc.subject.ocdehttps://purl.org/pe-repo/ocde/ford#3.02.26
dc.type.otherCommentary, Perspective u Opinion
dc.identifier.journalThe Lancet Healthy Longevity
dc.type.versionhttps://purl.org/coar/version/c_970fb48d4fbd8a85


Files in this item

Thumbnail

This item appears in the following Collection(s)

Show simple item record

https://purl.org/coar/access_right/c_abf2
Except where otherwise noted, this item's license is described as https://purl.org/coar/access_right/c_abf2